Donald Trump’s proposed 200% tariff on generic drug imports is less a blow to India’s pharmaceutical industry than a costly gamble that could leave American patients paying the highest price.
In the wake of Pompeo’s visit, we need to establish a clear, well-defined foreign policy that focuses a bit less on rhetoric and more on a long-term vision of our place in the world.